Summary of "In This MARKET CRASH... 4 Stocks That Promoters Have Bought | Rahul Jain"

Presenter / source

Rahul Jain — SEBI-registered research analyst.
Analysis based on insider‑trading filings, company quarterly results / con‑call commentary, annual reports and other public disclosures.
Video recorded ~20 March 2026.

Possible reasons promoters buy shares:

Important checks when observing insider/promoter buys:

Confirm instrument bought (equity vs debenture/bond). Promoter “buys” can be non‑equity.
Check quantities and purchase price versus current market price.
Compare valuations to historical metrics (10‑year median, lows, highs).
Drill into recent quarterly numbers to understand one‑offs (provisions, labour‑code impacts).
Review operational metrics (AUM growth, segment growth, deal pipeline) and management commentary.
Assess macro and sector risks (liquidity, credit cost, war impacts).

Caution: promoter buying is a positive signal but not a guarantee — price may still fall. Do your own due diligence. Not a buy/sell recommendation.

Ongoing war (Middle East) as of March 2026 → headline market weakness and sectoral operational risks (energy, supply chains, retail exposure in the Middle East).
Key macro risks for banks/NBFCs: tightening liquidity, rising credit costs, inflation — these can pressure financial‑sector earnings.
Gold flows / global rates: higher US yields and dollar bond attractiveness can pull money away from gold, impacting jewellery retailers.

(Tickers not provided in transcript)

Insider detail:
- Promoter purchases on 29 Dec 2025 — large market purchases (~900k shares reported).
- Bajaj Life Insurance bought debentures (non‑equity) on 10 Mar 2026.
Valuation metrics:
- 10‑year median P/B ≈ 8.1; current P/B ≈ 5; lowest ~4.7 (Nov 2024). Cheaper than long‑run median but not at absolute low.
Q3 (Dec 2025) headline numbers:
- Net profit: 4,066 crore vs previous quarter 4,948 crore and Dec‑24 4,308 crore (headline decline).
- Provisions ~1,406 crore in Q3 FY26; labour‑code impact ~265 crore.
- Pre‑provision profit and PAT (pre‑provision) were strong: pre‑provision PAT grew ~23% YoY; headline PAT down ~6% after provisions.
Operational metrics:
- AUM growth healthy across most loan products (20–27% range).
- Mortgages: ~30.7% of AUM; grew ~25%.
- Captive 2/3‑wheeler finance declined ~57% but is small (~3.2% of AUM).
Strategic / tech note:
- Heavy AI adoption: ~20 million customer calls analysed, ~520k customers processed, ~100k new offers created (product/efficiency use case).
Risks:
- Market volatility (war), liquidity tightening, rising credit costs, possible further valuation/price fall.
- Recommendation: read annual report and perform detailed diligence.

Insider detail:
- Promoter group (Vamasundri Investments) bought shares in March 2026 (examples: 17 Mar; reported buys include ~84k and “almost two lakh” shares).
Deal pipeline / bookings:
- Q3 FY26 net new bookings (TCV) = $3 billion — multi‑quarter high; +17% QoQ and +43% YoY.
- Red flag: management growth guidance modest (4.75–5.25%); investors question conversion of pipeline into revenue.
AI and revenue contribution:
- Advanced AI services grew ~19.9%.
- One large AI deal: 5‑year TCV ≈ $473 million.
- HCL’s share of AI in pipeline estimated ~25–30% (higher percentage than some peers, though absolute base differs).
M&A / spend:
- Multiple acquisitions in recent quarters to buy AI / niche capabilities; inorganic spend noted.
Valuation vs peers:
- P/E ≈ 20.74 (HCL) vs Infosys ≈ 17.23 vs TCS ≈ 16.74 — HCL trading at a premium to major peers.
Key questions / risks:
- Pipeline conversion to revenue.
- Valuation premium and effectiveness of inorganic spend.
- Suitability depends on investor’s growth vs value preference and portfolio downside protection.

Insider detail:
- JSL Overseas Holding bought shares repeatedly in late Feb / March 2026 (e.g., 269k shares on 17 Mar).
Operational / war impact disclosure (13 Mar 2026):
- Heavy dependency on industrial gases (propane, LPG, natural gas); supply disruption affected processes across plants and could force production halts if supplies are interrupted.
Demand outlook:
- Management noted healthy domestic demand across automotive, pipes & tubes, white goods, railways, metro projects.
Valuation / profitability:
- PE ≈ 19 (industry ≈ 19). PB ≈ 3.24 vs industry PB ≈ 1.48 (company higher).
- PEG negative due to YoY profit decline.
Sector notes and risks:
- Metals are cyclical and highly sensitive to commodity prices, energy supply, and international demand.
- Key operational risk: gas supply disruptions related to conflict.

Insider detail:
- Promoter T.S. Kalyanaraman bought in February 2026 (multiple batches: 11 Feb, 13 Feb).
Valuation history:
- 10‑year median P/E ≈ 47.7; current P/E ≈ 33.3.
- Peak P/E ~127.9 (Jan 2025); lowest ~18.8 (Aug 2022). Large historical P/E swings imply downside risk if valuations revert.
Geographic exposure / revenue mix:
- Middle East operations: ~38 showrooms; Middle East contributed ~12% of top line in FY25.
- Management noted a strong Middle East quarter pre‑war; war (late Feb/Mar 2026) introduces immediate uncertainty for these revenues and for Dubai‑centric gold logistics.
Financial trend (PAT progression cited):
- PAT series across successive years (as quoted): ~224 cr → 432 cr → 596 cr → 714 cr → 1,128 cr.
- Despite prior growth, macro uncertainty and valuation compression warrant caution.
Risks:
- Middle East war effects, shifts in global yields/inflation affecting gold demand, potential valuation re‑rating.
- Suggested action: add to watchlist and monitor valuation reversion before acting.

This is not buy/sell financial advice — insights only. Read company filings, con‑call transcripts, annual reports and do your own research.

Practical investor cautions:

Check instrument type (equity vs debt) when analysing promoter buys.
Compare current price/valuation to historical medians, lows, and highs to assess downside room.
Analyse causes of recent earnings changes (provisions, one‑offs) — not just headline PAT.
Consider macro risks (war, liquidity, credit costs, yields) and portfolio downside protection before allocating.
Avoid sharing stock picks without context (presenter discourages posting names without full analysis).

Dates and timelines: video recorded ~20 Mar 2026. Promoter buys concentrated in Feb–Mar 2026 (and Dec 29, 2025 for Bajaj). Q3 FY26 results referenced (Oct–Dec 2025).
Instruments noticed: equity shares, debentures (example: insurance arm bought debentures for Bajaj), deal TCVs, advanced AI services revenue contribution.
Performance metrics highlighted: net profits, provisions, AUM growth by business, P/B and P/E comparisons, TCV and net new bookings, QoQ and YoY growth rates.